Cerebellum GP LLC boosted its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 47.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,648 shares of the medical instruments supplier’s stock after acquiring an additional 2,774 shares during the period. Cerebellum GP LLC’s holdings in DENTSPLY SIRONA were worth $461,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also modified their holdings of the business. Advisor Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 25.9% in the 1st quarter. Advisor Group Inc. now owns 19,314 shares of the medical instruments supplier’s stock valued at $957,000 after buying an additional 3,978 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at about $379,000. FIL Ltd bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at about $3,281,000. Bayesian Capital Management LP bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at about $3,174,000. Finally, Allstate Corp bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at about $211,000. Institutional investors own 94.67% of the company’s stock.
A number of research firms have recently weighed in on XRAY. Barrington Research restated a “buy” rating and issued a $63.00 price target on shares of DENTSPLY SIRONA in a report on Monday, August 5th. ValuEngine cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Wednesday, October 2nd. Evercore ISI began coverage on shares of DENTSPLY SIRONA in a report on Friday, July 26th. They issued an “in-line” rating on the stock. BidaskClub upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Tuesday. Finally, HC Wainwright restated a “neutral” rating and issued a $57.00 price target (up from $55.00) on shares of DENTSPLY SIRONA in a report on Tuesday, July 9th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $54.57.
Shares of DENTSPLY SIRONA stock opened at $54.11 on Friday. The firm has a market capitalization of $12.13 billion, a P/E ratio of 26.92, a PEG ratio of 1.92 and a beta of 0.98. The company has a quick ratio of 1.39, a current ratio of 2.08 and a debt-to-equity ratio of 0.30. The company has a 50 day moving average price of $52.12 and a 200 day moving average price of $53.55. DENTSPLY SIRONA Inc has a 52 week low of $33.93 and a 52 week high of $59.40.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, August 2nd. The medical instruments supplier reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.04. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.04 billion. DENTSPLY SIRONA had a net margin of 2.67% and a return on equity of 9.19%. DENTSPLY SIRONA’s revenue was down 3.1% on a year-over-year basis. During the same period last year, the firm posted $0.60 EPS. As a group, research analysts anticipate that DENTSPLY SIRONA Inc will post 2.39 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were given a $0.10 dividend. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.40 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend was Thursday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 19.90%.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Article: volatile stocks
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.